Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
22916 | 308 | 29.6 | 43% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
339 | 17217 | CHLOROETHYLCLONIDINE//ALPHA1 ADRENOCEPTOR SUBTYPE//BETA3 ADRENOCEPTORS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | AGONIST AFFINITY | Author keyword | 3 | 33% | 2% | 7 |
2 | OPERATIONAL MODEL OF AGONISM | Author keyword | 2 | 38% | 2% | 5 |
3 | IRREVERSIBLE RECEPTOR INACTIVATION METHOD | Author keyword | 1 | 100% | 1% | 2 |
4 | FUNCTIONAL ANTAGONISM | Author keyword | 1 | 18% | 2% | 7 |
5 | SPARE RECEPTOR | Author keyword | 1 | 29% | 1% | 4 |
6 | MYOCARDIAL NOREPINEPHRINE | Author keyword | 1 | 40% | 1% | 2 |
7 | ANALYTICAL PHARMACOLOGY | Author keyword | 1 | 50% | 0% | 1 |
8 | CHENG PRUSOFF | Author keyword | 1 | 50% | 0% | 1 |
9 | CHENG PRUSOFF EQUATION | Author keyword | 1 | 50% | 0% | 1 |
10 | EFFICACY DISTRIBUTION | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BINDING FREQUENCY | 6 | 100% | 1% | 4 |
2 | AGONIST DISSOCIATION CONSTANTS | 3 | 57% | 1% | 4 |
3 | PRUSOFF | 3 | 60% | 1% | 3 |
4 | OPERATIONAL MODEL | 2 | 15% | 3% | 10 |
5 | INDUCED SUPER SENSITIVITY | 1 | 50% | 1% | 2 |
6 | PHARMACOLOGICAL AGONISM | 1 | 12% | 3% | 8 |
7 | COMPLEX OCCUPANCY MECHANISMS | 1 | 33% | 1% | 2 |
8 | NULL METHOD | 1 | 50% | 0% | 1 |
9 | PHARMACOLOGICAL ESTIMATION | 1 | 22% | 1% | 2 |
10 | INHIBITION CURVES | 0 | 20% | 1% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Assessing the (a)symmetry of concentration-effect curves: empirical versus mechanistic models | 2002 | 51 | 29 | 28% |
Why the Schild method is better than Schild realised | 2007 | 15 | 12 | 42% |
DEFINITION OF PHARMACOLOGICAL RECEPTORS | 1992 | 105 | 40 | 25% |
Assessing receptor affinity for inverse agonists: Schild and Cheng-Prusoff methods revisited | 2007 | 11 | 26 | 31% |
A personal view of pharmacology | 1996 | 30 | 22 | 18% |
Agonist binding, agonist affinity and agonist efficacy at G protein-coupled receptors | 2008 | 33 | 57 | 14% |
SCHILD REGRESSIONS AS INDICATORS OF NON-EQUILIBRIUM STEADY-STATES AND HETEROGENEOUS RECEPTOR POPULATIONS | 1985 | 33 | 7 | 86% |
Modeling of G-protein-coupled Receptor Signaling Pathways | 2009 | 14 | 54 | 11% |
RECEPTOR DISCRIMINATION AND CONTROL OF AGONIST-ANTAGONIST BINDING | 1995 | 16 | 26 | 19% |
International Union of Pharmacology. XIX. The IUPHAR receptor code: A proposal for an alphanumeric classification system | 1998 | 15 | 42 | 10% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GLENFIELD GEN HOSP MED ELDERLY | 1 | 50% | 0.3% | 1 |
2 | MED INTERNAL MED 1 11 SEIRYO MACHI | 0 | 20% | 0.3% | 1 |
3 | KATEDRA FIZJOL BIOCHEM FARMAKOL TOKSYKOL | 0 | 17% | 0.3% | 1 |
4 | CASILLA 2407 | 0 | 10% | 0.3% | 1 |
5 | 68 HALF MOON LANE | 0 | 100% | 0.3% | 1 |
6 | GRP BIOMAT REC | 0 | 100% | 0.3% | 1 |
7 | PHARMACOL ESCOLA PAULISTA MED | 0 | 100% | 0.3% | 1 |
8 | SAFETY PHARMACOL DRUG SAFETY EVALUAT | 0 | 100% | 0.3% | 1 |
9 | SELLY OAK HOSP MED ELDERLY | 0 | 100% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000124081 | INTACT CELL BINDING//DIABET METAB DIS PROGRAM//GENE REPRESSOR |
2 | 0.0000119386 | POSTJUNCTIONAL ALPHA 2 ADRENOCEPTORS//UK14304//ALPHA 1 ADRENOCEPTORS |
3 | 0.0000117838 | T 0509//ZINTEROL//BETA ADRENERGIC RECEPTOR SUBTYPE |
4 | 0.0000111325 | AGONIST ANTAGONIST DISCRIMINATION//BINDING THERMODYNAMICS//W SSM RATS |
5 | 0.0000104856 | CAS 76963 41 2//MIFENTIDINE//HISTAMINE H 2 RECEPTORS |
6 | 0.0000102898 | RHYTHMICAL CONTRACTIONS//SEROTONIN2A RECEPTORS//MOTILITY ANALYSIS |
7 | 0.0000097183 | XAMOTEROL//EPANOLOL//DENOPAMINE |
8 | 0.0000095581 | GTP REGULATORY PROTEINS//INOSITOL TRISPHOSPHATE PHOSPHATASE//POSITIVE INOTROPIC EFFECT |
9 | 0.0000094144 | TRANS MEMBRANE CONDUCTANCE//ONSAGER RECIPROCITY THEOREM//INSTANTANEOUS RATE |
10 | 0.0000090952 | ALPHA BETA ADRENOCEPTOR BLOCKADE//KMUP 1//EUGENOSEDIN A |